Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Polysialic acid is a linear homopolymer of sialic acid residues, commonly composed of α2,8-linked or α2,9-linked N-acetylneuraminic acid units[1][3]. It is primarily known as a post-translational modification of the neural cell adhesion molecule (NCAM) in vertebrates, dramatically altering cell–cell interactions due to its large size and strong negative charge[1][4][8]. Polysialic acid has a prominent role in neural development, cell migration, synapse formation, axon guidance, and the modulation of immune cell functions. Its biological effects are driven by its anti-adhesive, hydration, and charge-shielding properties. In cancer, polySia is linked to enhanced metastatic potential, and in certain pathogenic bacteria (such as Neisseria meningitidis), it forms the bacterial capsule, facilitating immune evasion[3][9]. Polysialic acid is not itself a druggable target, enzyme, receptor, or transporter but is a unique, regulated glycan modification on specific proteins, most notably NCAM.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Polysialic acid (polySia).